Trials / Completed
CompletedNCT00291213
Levetiracetam Treatment of Tardive Dyskinesia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levetiracetam | |
| DRUG | placebo |
Timeline
- Primary completion
- 2006-04-01
- First posted
- 2006-02-13
- Last updated
- 2014-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00291213. Inclusion in this directory is not an endorsement.